The Impact of the Act for the Development of Biotech and New Pharmaceuticals Industry on Firm Innovation in Taiwan

生技新藥產業發展條例對公司創新影響

10.6226/NTUMR.202108_31(2).0005

梁婉麗(Woan-lih Liang)；劉泰承(Tai-Cheng Liu)

innovation ； R&D ； tax credits ； propensity score matching ； difference-in-difference ； 研發創新 ； 課稅抵減 ； 傾向分數配對法 ； 差異中之差異法 ； 生技新藥業發展條例

臺大管理論叢

31卷2期（2021 / 08 / 01）

129 - 188

英文

This study investigates how the innovation activities of the biotech and new pharmaceuticals industry (biopharmaceutical industry) change after the exogenous shock of the enactment of the Act for the Development of Biotech and New Pharmaceuticals Industry (Biopharmaceutical Act). We adopt Propensity Score Matching (PSM) and Difference-in-difference (DID) approaches to deal with sample selection bias and endogeneity problems. We find that approved biopharmaceutical firms engage in more innovation investments after the passage of the Biopharmaceutical Act than unapproved firms. We also confirm the policy effectiveness of the Biopharmaceutical Act, finding that approved biopharmaceutical firms are more encouraged to engage in innovation activities than high-tech firms after the Biopharmaceutical Act. In addition, the stimulation effect on innovation exists only for pharmaceutical and low R&D intensity firms. In the subsample analysis of the inter-industry effects, the stimulation effect is driven primarily by low R&D intensity firms and small firms. These findings consolidate the effectiveness of the Biopharmaceutical Act for biopharmaceutical firms with more serious R&D underinvestment problems. Our investigation also shows the effectiveness of tax credits granted by the Biopharmaceutical Act for the R&D investment of biopharmaceutical firms in Taiwan.

本研究探討生技新藥業發展條例（簡稱生技條例）對生技新藥業（簡稱生技業）研發創新的影響。我們採用「傾向分數配對法」與「差異中之差異法」來處理樣本選擇誤差與內生性問題。研究發現，在生技條例施行後，經生技條例核可的公司比未經核可的公司有較多的研發創新。我們也發現在生技條例施行後，經條例核可的公司會比高科技公司有較多的研發創新。再者，經生技條例核可的公司中，新藥公司與研發強度低的公司會致力於較多的研發創新。與高科技公司比較時，生技條例核可的公司中，研發強度較低的公司與小公司會有較多的研發創新。這些發現隱含條例對於研發較嚴重投資不足的公司的激勵效果較強。我們的研究亦驗證政府對於生技業所提供的課稅減免優惠對刺激該產業投資研發創新有正向的鼓勵作用。

1. 黃政仁, C. J.,張肇元, C. Y.(2020)。董事連結網絡特性、技術多角化與創新績效之關聯性研究：以臺灣電子業為例。臺大管理論叢，30(3)，145-182。
   連結：
2. 黃美祝, M. J.(2019)。董事連結與企業避稅程度之關聯性。臺大管理論叢，29(2)，201-232。
   連結：
3. Aerts, K.,Schmidt, T.(2008).Two for the price of one?: Additionality effects of R&D subsidies: A comparison between Flanders and Germany.Research Policy,37(5),806-822.
4. Aghion, P.,Howitt, P.(1992).A model of growth through creative destruction.Econometrica,60(2),323-351.
5. Aghion, P.,Van Reenen, J.,Zingales, L.(2013).Innovation and institutional ownership.The American Economic Review,103(1),277-304.
6. Arrow, K.(1962).Economic welfare and the allocation of resources for invention.The Rate and Direction of Inventive Activity: Economic and Social Factors,Princeton, NJ:
7. Artz, K. W.,Norman, P. M.,Hatfield, D. E.,Cardinal, L. B.(2010).A longitudinal study of the impact of R&D, patents, and product innovation on firm performance.Journal of Product Innovation Management,27(5),725-740.
8. Baghana, R.,Mohnen, P.(2009).Effectiveness of R&D tax incentives in small and large enterprises in Québec.Small Business Economics,33(1),91-107.
9. Becker, B.(2015).Public R&D policies and private R&D investment: A survey of the empirical evidence.Journal of Economic Surveys,29(5),917-942.
10. Becker-Blease, J. R.(2011).Governance and innovation.Journal of Corporate Finance,17(4),947-958.
11. Bena, J.,Li, K.(2014).Corporate innovations and mergers and acquisitions.The Journal of Finance,69(5),1923-1960.
12. Bessen, J.,Neuhäusler, P.,Turner, J. L.,Williams, J.(2014).The costs and benefits of United States patents.SSRN Electronic Journal
13. Bhattacharya, M.,Bloch, H.(2004).Determinants of innovation.Small Business Economics,22(2),155-162.
14. Blundell, R.,Costa-Dias, M.(2009).Alternative approaches to evaluation in empirical microeconomics.Journal of Human Resources,44(3),565-640.
15. Brown, J. R.,Fazzari, S. M.,Petersen, B. C.(2009).Financing innovation and growth: Cash flow, external equity, and the 1990s R&D boom.The Journal of Finance,64(1),151-185.
16. Brown, J. R.,Martinsson, G.,Petersen, B. C.(2017).What promotes R&D? Comparative evidence from around the world.Research Policy,46(2),447-462.
17. Brown, J. R.,Martinsson, G.,Petersen, B. C.(2012).Do financing constraints matter for R&D?.European Economic Review,56(8),1512-1529.
18. Buckley, J.,Shang, Y.(2002).Estimating policy and program effects with observational data: The “differences-in-differences” estimator.Practical Assessment, Research, and Evaluation,8,Article 24.
19. Bushee, B. J.(1998).The influence of institutional investors on myopic R&D investment behavior.The Accounting Review,73(3),305-333.
20. Caliendo, M.,Kopeinig, S.(2008).Some practical guidance for the implementation of propensity score matching.Journal of Economic Surveys,22(1),31-72.
21. Carboni, O. A.(2011).R&D subsidies and private R&D expenditures: Evidence from Italian manufacturing data.International Review of Applied Economics,25(4),419-439.
22. Cerulli, G.,Potì, B.(2012).Evaluating the robustness of the effect of public subsidies on firms’ R&D: An application to Italy.Journal of Applied Economics,15(2),287-320.
23. Chan, L. K. C.,Lakonishok, J.,Sougiannis, T.(2001).The stock market valuation of research and development expenditures.The Journal of Finance,56(6),2431-2456.
24. Chang, H. Y.,Liang, W. L.,Wang, Y.(2019).Do institutional investors still encourage patent-based innovation after the tech bubble period?.Journal of Empirical Finance,51,149-164.
25. Chang, X.,Fu, K.,Low, A.,Zhang, W.(2015).Non-executive employee stock options and corporate innovation.Journal of Financial Economics,115(1),168-188.
26. Chen, S. S.,Chen, Y. S.,Liang, W. L.,Wang, Y.(2013).R&D spillover effects and firm performance following R&D increases.Journal of Financial and Quantitative Analysis,48(5),1607-1634.
27. Chen, S. S.,Chen, Y. S.,Liang, W. L.,Wang, Y.(2020).Public R&D spending and cross-sectional stock returns.Research Policy,49(1)
28. Cohen, W. M.,Nelson, R. R.,Walsh, J. P.(2000).NBER Working PaperNBER Working Paper,Cambridge, MA:National Bureau of Economic Research.
29. Connolly, R. A.,Hirschey, M.(2005).Firm size and the effect of R&D on Tobin’s q.R&D Management,35(2),217-223.
30. Czarnitzki, D.,Hanel, P.,Rosa, J. M.(2011).Evaluating the impact of R&D tax credits on innovation: A microeconometric study on Canadian firms.Research Policy,40(2),217-229.
31. Czarnitzki, D.,Hussinger, K.(2004).ZEW-Centre for European Economic Research Discussion PaperZEW-Centre for European Economic Research Discussion Paper,Mannheim, Germany:Leibniz Center for European Economic Research.
32. David, P. A.,Hall, B. H.,Toole, A. A.(2000).Is public R&D a complement or substitute for private R&D? A review of the econometric evidence.Research Policy,29(4-5),497-529.
33. Dehejia, R. H.,Wahba, S.(2002).Propensity score-matching methods for nonexperimental causal studies.The Review of Economics and Statistics,84(1),151-161.
34. Duguet, E.(2004).Are R&D subsidies a substitute or a complement to privately funded R&D? An econometric analysis at the firm level.Revue D’Economie Politique,114(2),245-274.
35. Eisner, R.,Albert, S. H.,Sullivan, M. A.(1984).The new incremental tax credit for R&D: Incentive or disincentive?.National Tax Journal,37(2),171-183.
36. Franzen, L. A.,Rodgers, K. J.,Simin, T. T.(2007).Measuring distress risk: The effect of R&D intensity.The Journal of Finance,62(6),2931-2967.
37. Greve, H. R.(2003).A behavioral theory of R&D expenditures and innovations: Evidence from shipbuilding.Academy of Management Journal,46(6),685-702.
38. Griliches, Z.(1990).Patent statistics as economic indicators: A survey.Journal of Economic Literature,28(4),1661-1707.
39. Griliches, Z.(1981).Market value, R&D, and patents.Economics Letters,7(2),183-187.
40. Hægeland, T.,Møen, J.(2007).Statistics Norway ReportsStatistics Norway Reports,Oslo, Norway:Statistics Norway’s Information Centre.
41. Hall, B. H.(2002).The financing of research and development.Oxford Review of Economic Policy,18(1),35-51.
42. Hall, B. H.(1993).R&D tax policy during the 1980s: Success or failure?.Tax Policy and the Economy,7,1-35.
43. Hall, B. H.,Jaffe, A. B.,Trajtenberg, M.(2001).NBER Working PapersNBER Working Papers,Cambridge, MA:National Bureau of Economic Research.
44. Hall, B. H.,Jaffe, A. B.,Trajtenberg, M.(2005).Market value and patent citations.The RAND Journal of Economics,36(1),16-38.
45. Hall, B. H.,Van Reenen, J.(2000).How effective are fiscal incentives for R&D? A review of the evidence.Research Policy,29(4-5),449-469.
46. Heckman, J. J.,Ichimura, H.,Todd, P. E.(1997).Matching as an econometric evaluation estimator: Evidence from evaluating a job training programme.The Review of Economic Studies,64(4),605-654.
47. Hitt, M. A.,Hoskisson, R. E.,Ireland, R. D.,Harrison, J. S.(1991).Effects of acquisitions on R&D inputs and outputs.Academy of Management Journal,34(3),693-706.
48. Hsu, P. H.(2009).Technological innovations and aggregate risk premiums.Journal of Financial Economics,94(2),264-279.
49. Hsu, P. H.,Tian, X.,Xu, Y.(2014).Financial development and innovation: Cross-country evidence.Journal of Financial Economics,112(1),116-135.
50. Jones, C. I.,Williams, J. C.(1998).Measuring the social return to R&D.The Quarterly Journal of Economics,113(4),1119-1135.
51. Klassen, K. J.,Pittman, J. A.,Reed, M. P.,Fortin, S.(2004).A cross-national comparison of R&D expenditure decisions: Tax incentives and financial constraints.Contemporary Accounting Research,21(3),639-680.
52. Klette, T. J.,Møen, J.(2012).R&D investment responses to R&D subsidies: A theoretical analysis and a microeconometric study.World Review of Science, Technology and Sustainable Development,9(2-4),169-203.
53. Klette, T. J.,Møen, J.,Griliches, Z.(2000).Do subsidies to commercial R&D reduce market failures? Microeconomitric evaluation studies.Research Policy,29(4-5),471-495.
54. Kong, L.(2020).Government spending and corporate innovation.Management Science,66(4),1584-1604.
55. Lach, S.(2002).Do R&D subsidies stimulate or displace private R&D? Evidence from Israel.The Journal of Industrial Economics,50(4),369-390.
56. Lane, W. R.,Looney, S. W.,Wansley, J. W.(1986).An application of the cox proportional hazards model to bank failure.Journal of Banking and Finance,10(4),511-531.
57. Lechner, M.(2011).The estimation of causal effects by difference-in-difference methods.Foundations and Trends in Econometrics,4(3),165-224.
58. Lerner, J.(1994).The importance of patent scope: An empirical analysis.The RAND Journal of Economics,25(2),319-333.
59. Li, D.(2011).Financial constraints, R&D investment, and stock returns.The Review of Financial Studies,24(9),2974-3007.
60. Li, G. C.,Lai, R.,D’amour, A.,Doolin, D. M.,Sun, Y.,Torvik, V. I.,Yu, A. Z.,Fleming, L.(2014).Disambiguation and co-authorship networks of the U.S. patent inventor database (1975-2010).Research Policy,43(6),941-955.
61. Lokshin, B.,Mohnen, P.(2012).How effective are level-based R&D tax credits? Evidence from the Netherlands.Applied Economics,44(12),1527-1538.
62. Mansfield, E.(1986).The R&D tax credit and other technology policy issues.The American Economic Review,76(2),190-194.
63. Özçelik, E.,Taymaz, E.(2008).R&D support programs in developing countries: The Turkish experience.Research Policy,37(2),258-275.
64. Porter, M. E.(1992).Capital disadvantage: America’s failing capital investment system.Harvard Business Review,70(5),65-82.
65. Romer, P. M.(1990).Endogenous technological change.Journal of Political Economy,98(5),S71-S102.
66. Rosenbaum P. R.,Rubin, D. B.(1983).The central role of the propensity score in observational studies for causal effects.Biometrika,70(1),41-55.
67. Shefer, D.,Frenkel, A.(2005).R&D, firm size and innovation: An empirical analysis.Technovation,25(1),25-32.
68. Takalo, T.,Tanayama, T.(2010).Adverse selection and financing of innovation: Is there a need for R&D subsidies?.The Journal of Technology Transfer,35(1),16-41.
69. Tillinger, J. W.(1991).An analysis of the effectiveness of the research and experimentation tax credit in a q model of valuation.Journal of the American Taxation Association,13(2),1-29.
70. Toivanen, O.,Niininen, P.(2000).HSEBA Working PaperHSEBA Working Paper,Helsinki, Finland:Department of Economics MIT.
71. Trajtenberg, M.(1990).A penny for your quotes: Patent citations and the value of innovations.The RAND Journal of Economics,21(1),172-187.
72. Wallsten, S. J.(2000).The effects of government-industry R&D programs on private R&D: The case of the small business innovation research program.The RAND Journal of Economics,31(1),82-100.
73. Wernerfelt, B.,Montgomery, C. A.(1988).Tobin’s q and the importance of focus in firm performance.The American Economic Review,78(1),246-250.
74. Winston, C.(2006).Government Failure versus Market Failure: Microeconomics Policy Research and Government Performance.Washington, DC:AEI-Brookings Joint Center for Regulatory Studies.
75. Wu, Y.(2005).The effects of state R&D tax credits in simulating private R&D expenditure: A cross-state empirical analysis.Journal of Policy Analysis and Management,24(4),785-802.
76. Yang, C. H.,Huang, C. H.,Hou, T. C. T.(2012).Tax incentives and R&D activity: Firm-level evidence from Taiwan.Research Policy,41(9),1578-1588.
77. 中華民國創業投資商業同業公會=Taiwan Venture Capital Association(2008).2008 年臺灣創業投資年鑑.臺北,臺灣=Taipei, Taiwan:經濟部工業局=Industrial Development Bureau, Ministry of Economic Affairs.
78. 孫智麗, J. C. L.(2003)。臺灣生技產業發展現況與產業創新策略。經濟情勢及評論季刊，9(2)，113-139。
79. 翁啟惠, C. H.(2007)。政策焦點：生技製藥產業在台灣的發展（2007年7月總統府月會專題報告）。台灣經濟論衡，5(8)，3-23。
80. 高曼蓉, M. J.(2012)。臺北，臺灣=Taipei, Taiwan，國立臺灣大學經濟學研究所=Department of Economics, National Taiwan University。
81. 許淑燕, S. Y.(2018)。臺北，臺灣=Taipei, Taiwan，國立政治大學經營管理碩士學程=Executive Master Business Administration, National Chengchi University。
82. 陳怡君, Y. C.(2017)。臺北，臺灣=Taipei, Taiwan，國立政治大學科技管理與智慧財產研究所=Graduate Institute of Technology, Innovation & Intellectual Property Management, National Chengchi University。
83. 陳欣喬, H. C.(2013)。臺北，臺灣=Taipei, Taiwan，東吳大學會計學研究所=Department of Accounting, Soochow University。
84. 經濟部工業局=Ministry of Economic Affairs(2018).2018 生技產業白皮書.臺北,臺灣=Taipei, Taiwan:經濟部工業局=Industrial Development Bureau, Ministry of Economic Affairs.

1. 劉若蘭,周育祥(2023)。企業創新能力和董事會多樣性對聘任審計產業專家之影響。當代會計，24(2)，215-250。
2. (2024)。委託決策、委託交易品質與成交量能：加快撮合之實證觀察。臺大管理論叢，34(2)，139-184。